Results 31 to 40 of about 113,465 (266)

Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis

open access: yesActa Dermato-Venereologica, 2022
Cholestatic itch is a disabling symptom that may be secondary to liver or biliary diseases. Management of cholestatic pruritus is complex. A systematic review and meta-analysis on the efficacy of treatments for cholestatic pruritus were performed. PubMed
Charles Dervout   +5 more
doaj   +1 more source

Determining the Prevalence of Rifampicin Resistant Tuberculosis in A Tertiary Care Centre of North India by using Rapid Culture Method and Gene Xpert

open access: yesJournal of Pure and Applied Microbiology, 2021
The objective of the present study is to find the prevalence of Mycobacterium tuberculosis from respiratory samples like sputum, BAL and pleural fluid, compare conventional LJ culture with rapid culture method i.e Mycobacterium growth indicator tube ...
Bipin Chandra Pokhriyal   +5 more
doaj   +1 more source

High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study) [version 1; referees: 2 approved]

open access: yesWellcome Open Research, 2018
Background: Tuberculous meningitis (TBM) has 44% (95%CI 35-52%) in-hospital mortality with standard therapy in Uganda. Rifampicin, the cornerstone of TB therapy, has 70% oral bioavailability and ~10-20% cerebrospinal fluid (CSF) penetration.
Fiona V. Cresswell   +13 more
doaj   +1 more source

A rare case of tuberculosis spine on antitubercular drug succumbing to pseudomembranous enterocolitis

open access: yesJournal of Dr. NTR University of Health Sciences, 2021
Anti-tubercular therapy (ATT) drugs are the mainstay of management of tuberculosis worldwide. These medicines are used extensively across the globe in treating tubercular infections of any organ.
Simarjit S Rehsi   +6 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre.

open access: yesPLoS ONE, 2019
BackgroundRecent evidence suggests that higher rifampicin doses may improve tuberculosis (TB) treatment outcome.MethodsIn this observational cohort study we evaluated all TB patients who were treated with high-dose rifampicin (> 10 mg/kg daily) in our ...
Charlotte Seijger   +9 more
doaj   +1 more source

Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin [PDF]

open access: yes, 2005
Human islet amyloid polypeptide (hIAPP) forms amyloid deposits in non-insulin-dependent diabetes mellitus (NIDDM). Pre-fibrillar hIAPP oligomers (in contrast to monomeric IAPP or mature fibrils) increase membrane permeability, suggesting an important ...
Bradshaw, Jeremy P.   +14 more
core   +1 more source

EFFECTIVENESS OF REAL-TIME PCR FOR EXPRESS FIRST LINE DRUG SUSCEPTIBILITY TESTING OF TUBERCULOUS MYCOBACTERIA USING SPUTUM SAMPLES AND SURGICAL SPECIMENS OF LUNG TISSUE

open access: yesТуберкулез и болезни лёгких, 2019
The objective of the study: to investigate the effectiveness of real-time PCR for express drug susceptibility testing in drug resistant pulmonary tuberculosis patients using sputum samples and specimens of lung tissue collected during surgery.Subjects ...
Yu. S. Alyapkina   +3 more
doaj   +1 more source

Early Detection of Multi-drug Resistant Tuberculosis and Mutations in Mycobacterium tuberculosis isolates using Line Probe Assay from a Tertiary Care Centre in Northern India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Introduction: Early detection and drug susceptibility analysis of Mycobacterium tuberculosis (MTB) in the shortest possible time has been the driving force for research that aims to bridge the gap between detection and treatment.
Omar Rashid   +6 more
doaj   +1 more source

The tale of microencapsulated rifampicin: is it useful for the treatment of periprosthetic joint infection?

open access: yes, 2022
CRUE-CSIC (Acuerdos Transformativos 2021)Purpose Microencapsulation techniques have allowed the addition of rifampicin to bone cement, but its in vivo efficacy has not been proven. The aim of our study is to determine the superiority of cement containing
López Torres, Irene Isabel   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy